Tumor Growth Suppression and Enhanced Radioresponse by an Exogenous Epidermal Growth Factor in Mouse Xenograft Models with A431 Cells

Purpose The purpose of this study was to evaluate whether an exogenous epidermal growth factor (EGF) could induce anti-tumor and radiosensitizing effects in vivo. Materials and Methods BALB/c-nu mice that were inoculated with A431 (human squamous cell carcinoma) cells in the right hind legs were divided into five groups: I (no treatment), II (EGF for 6 days), III (EGF for 20 days), IV (radiotherapy [RT]), and V (RT plus concomitant EGF). EGF was administered intraperitoneally (5 mg/kg) once a day and the RT dose was 30 Gy in six fractions. Hematoxylin and eosin (H&E) stained sections of tumor, liver, lung, and kidney tissues were investigated. Additionally, tumors were subjected to immunohistochemistry staining with caspase-3. Results EGF for 6 days decreased tumor volume, but it approached the level of the control group at the end of follow-up (p=0.550). The duration of tumor shrinkage was prolonged in group V while the slope of tumor re-growth phase was steeper in group IV (p=0.034). EGF for 20 days decreased tumor volume until the end of the observation period (p < 0.001). Immunohistochemistry revealed that mice in group V showed stronger intensity than those in group IV. There were no abnormal histological findings upon H&E staining of the normal organs. Conclusion EGF-induced anti-tumor effect was ascertained in the xenograft mouse models with A431 cells. Concomitant use of EGF has the potential role as a radiosensitizer in the design of fractionated irradiation.

[1]  N. Nikolsky,et al.  p38 MAP kinase enhances EGF-induced apoptosis in A431 carcinoma cells by promoting tyrosine phosphorylation of STAT1. , 2013, Biochemical and biophysical research communications.

[2]  Jamie S. Rush,et al.  Endosomal Accumulation of the Activated Epidermal Growth Factor Receptor (EGFR) Induces Apoptosis* , 2011, The Journal of Biological Chemistry.

[3]  T. Negri,et al.  Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Jene Choi,et al.  Epidermal Growth Factor Induces Cell Death in the Absence of Overexpressed Epidermal Growth Factor Receptor and ErbB2 in Various Human Cancer Cell Lines , 2010, Cancer investigation.

[5]  Sang‐wook Lee,et al.  Differential Effects of Recombinant Human EGF on Proliferation and Radiation Survival of Normal Fibroblast and Cancer Cell Lines , 2009 .

[6]  S. Chang,et al.  Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells. , 2009, Cancer letters.

[7]  G. Tortora,et al.  EGFR antagonists in cancer treatment. , 2008, The New England journal of medicine.

[8]  N. Nikolsky,et al.  EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3. , 2007, European journal of cell biology.

[9]  B. Mirkin,et al.  Novel action of epidermal growth factor on caspase 3 and its potential as a chemotherapeutic adjunct for neuroblastoma. , 2007, Journal of pediatric surgery.

[10]  Felix Y. Feng,et al.  Integration of EGFR inhibitors with radiochemotherapy , 2006, Nature Reviews Cancer.

[11]  E. Henson,et al.  Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. , 2006, Cellular signalling.

[12]  Zhaosheng Lin,et al.  Epidermal growth factor induces cell cycle arrest and apoptosis of squamous carcinoma cells through reduction of cell adhesion , 2000, Journal of cellular biochemistry.

[13]  P. Harari,et al.  Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  J E Darnell,et al.  Epidermal growth factor-induced growth inhibition requires Stat1 activation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[15]  H. Wiley,et al.  Structural Aspects of the Epidermal Growth Factor Receptor Required for Transmodulation of erbB-2/neu* , 1997, The Journal of Biological Chemistry.

[16]  W. A. Yeudall,et al.  Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. , 1996, Oncogene.

[17]  A. Deblasio,et al.  Prolonged induction of p21Cip1/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition , 1995, The Journal of cell biology.

[18]  N. Maihle,et al.  The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities. , 1994, International journal of radiation oncology, biology, physics.

[19]  T. Kwok,et al.  Differences in EGF related radiosensitisation of human squamous carcinoma cells with high and low numbers of EGF receptors. , 1991, British Journal of Cancer.

[20]  T. Kwok,et al.  Enhancement of sensitivity of human squamous carcinoma cells to radiation by epidermal growth factor. , 1989, Journal of the National Cancer Institute.

[21]  S. Cohen,et al.  Epidermal growth factor , 1972, The Journal of investigative dermatology.

[22]  Jordi Giralt,et al.  Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. , 2010, The Lancet. Oncology.

[23]  T. Kwok,et al.  Cell cycle dependence of epidermal growth factor induced radiosensitization. , 1992, International journal of radiation oncology, biology, physics.